Literature DB >> 22106225

Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Marija Djukic1, Martin Munz, Fritz Sörgel, Ulrike Holzgrabe, Helmut Eiffert, Roland Nau.   

Abstract

In 1900, Ernst Overton found that the entry of anilin dyes through the cell membranes of living cells depended on the lipophilicity of the dyes. The brain is surrounded by barriers consisting of lipid layers that possess several inward and outward active transport systems. In the absence of meningeal inflammation, the cerebrospinal fluid (CSF) penetration of anti-infectives in humans estimated by the ratio of the area under the concentration-time curve (AUC) in CSF (AUC(CSF)) to that in serum (AUC(CSF)/AUC(S)) correlated positively with the lipid-water partition coefficient at pH 7.0 (log D) (Spearman's rank correlation coefficient r(S) = 0.40; P = 0.01) and negatively with the molecular mass (MM) (r(S) = -0.33; P = 0.04). The ratio of AUC(CSF) to the AUC of the fraction in serum that was not bound (AUC(CSF)/AUC(S,free)) strongly correlated with log D (r(S) = 0.67; P < 0.0001). In the presence of meningeal inflammation, AUC(CSF)/AUC(S) also correlated positively with log D (r(S) = 0.46; P = 0.002) and negatively with the MM (r(S) = -0.37; P = 0.01). The correlation of AUC(CSF)/AUC(S,free) with log D (r(S) = 0.66; P < 0.0001) was as strong as in the absence of meningeal inflammation. Despite these clear correlations, Overton's rule was able to explain only part of the differences in CSF penetration of the individual compounds. The site of CSF withdrawal (lumbar versus ventricular CSF), age of the patients, underlying diseases, active transport, and alterations in the pharmacokinetics by comedications also appeared to strongly influence the CSF penetration of the drugs studied.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22106225      PMCID: PMC3264201          DOI: 10.1128/AAC.00437-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  115 in total

Review 1.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Clin Infect Dis       Date:  2005-03-22       Impact factor: 9.079

2.  Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.

Authors:  Ronny Beer; Klaus W Engelhardt; Bettina Pfausler; Gregor Broessner; Raimund Helbok; Peter Lackner; Christian Brenneis; Stefan T Kaehler; Apostolos Georgopoulos; Erich Schmutzhard
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

Review 3.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

4.  Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study.

Authors:  Jean-Damien Ricard; Michel Wolff; Jean-Claude Lacherade; Bruno Mourvillier; Nadia Hidri; Guilène Barnaud; Guillaume Chevrel; Lila Bouadma; Didier Dreyfuss
Journal:  Clin Infect Dis       Date:  2006-12-15       Impact factor: 9.079

Review 5.  Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  Prog Neurobiol       Date:  2005-05       Impact factor: 11.685

Review 6.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV.

Authors:  Edmund V Capparelli; Diane Holland; Charles Okamoto; Bryan Gragg; Janis Durelle; Jennifer Marquie-Beck; Geoffrey van den Brande; Ron Ellis; Scott Letendre
Journal:  AIDS       Date:  2005-06-10       Impact factor: 4.177

8.  Rapid elimination of cefaclor from the cerebrospinal fluid is mediated by a benzylpenicillin-sensitive mechanism distinct from organic anion transporter 3.

Authors:  Misaki Kuroda; Hiroyuki Kusuhara; Hitoshi Endou; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2005-05-13       Impact factor: 4.030

9.  Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.

Authors:  Federico Pea; Ettore Ferrari; Federica Pavan; Derri Roman-Pognuz; Francesco Bandello; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

10.  Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients.

Authors:  Yu-Wei Chou; Yuan-Han Yang; Jin-Hon Chen; Chen-Chun Kuo; Su-Hwei Chen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-06-26       Impact factor: 3.205

View more
  7 in total

1.  Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration.

Authors:  L B Avery; N Sacktor; J C McArthur; C W Hendrix
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

Review 2.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

Review 3.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

4.  Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosis.

Authors:  Suresh B Lakshminarayana; Helena I M Boshoff; Joseph Cherian; Sindhu Ravindran; Anne Goh; Jan Jiricek; Mahesh Nanjundappa; Amit Nayyar; Meera Gurumurthy; Ramandeep Singh; Thomas Dick; Francesca Blasco; Clifton E Barry; Paul C Ho; Ujjini H Manjunatha
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

5.  Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.

Authors:  Shashikant Srivastava; Devyani Deshpande; Jotam Pasipanodya; Eric Nuermberger; Soumya Swaminathan; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2016-11-01       Impact factor: 9.079

6.  Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK Observations.

Authors:  Chie Emoto; Trevor N Johnson; Brooks T McPhail; Alexander A Vinks; Tsuyoshi Fukuda
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-02-15

Review 7.  Utility of CSF in translational neuroscience.

Authors:  Elizabeth C M de Lange
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-12       Impact factor: 2.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.